Copyright
©The Author(s) 2022.
World J Clin Cases. Apr 26, 2022; 10(12): 3698-3708
Published online Apr 26, 2022. doi: 10.12998/wjcc.v10.i12.3698
Published online Apr 26, 2022. doi: 10.12998/wjcc.v10.i12.3698
Figure 2 Karyopherin A2 expression.
Immunohistochemical staining (×400). A: High expression of Karyopherin A2 (KPNA2) in triple-negative breast cancer tissue; B: KPNA2 positive and low expression in non-triple-negative breast cancer tissue; C: Negative expression of KPNA2 in normal breast tissue.
- Citation: Ding F, Chen RY, Hou J, Guo J, Dong TY. Efficacy and prognostic factors of neoadjuvant chemotherapy for triple-negative breast cancer. World J Clin Cases 2022; 10(12): 3698-3708
- URL: https://www.wjgnet.com/2307-8960/full/v10/i12/3698.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v10.i12.3698